Fusion proteins specific for CD137 and GPC3
US-12486330-B2 · Dec 2, 2025 · US
This page is not indexed by search engines while we improve data quality.
Jaquin Thomas patents
Jaquin Thomas is listed as an inventor on 5 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Jaquin Thomas |
| Total patents | 5 |
| First publication | Aug 12, 2021 |
| Latest publication | Dec 2, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Novel lipocalin muteins specific for connective tissue growth factor (ctgf)
US-2024228562-A1 · Jul 11, 2024 · US
Inhaled administration of lipocalin muteins
US-2022168387-A1 · Jun 2, 2022 · US
Novel Fusion Proteins Specific for CD137 and GPC3
US-2022153864-A1 · May 19, 2022 · US
Combination therapies comprising cd137/her2 bispecific agents and pd-1 axis inhibitors and uses thereof
US-2021246219-A1 · Aug 12, 2021 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Pieris Pharmaceuticals Gmbh | 5 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| A61P35/00 | 5 |
| C07K2319/00 | 4 |
| C07K2317/92 | 3 |
| C07K2317/31 | 3 |
| C07K2318/20 | 3 |